We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Corindus Vascular Robotics, Inc. announced today that it has signed a definitive agreement to issue a newly designated Series A convertible preferred stock to a group of existing investors
Corindus Vascular Robotics Inc. announced today that it received 510(k) clearance from the FDA for the first automated robotic movement designed for the CorPath GRX platform.